Kymera Therapeutics, Inc.
KYMR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $120 | $110 | $68 | $48 |
| Short-Term Investments | $368 | $265 | $339 | $394 |
| Receivables | $1 | $19 | $3 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $21 | $12 | $10 | $9 |
| Total Curr. Assets | $510 | $405 | $419 | $451 |
| Property Plant & Equip (Net) | $98 | $101 | $22 | $21 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $362 | $61 | $152 | $125 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $8 | $8 | $9 | $8 |
| Total NC Assets | $468 | $170 | $184 | $155 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $978 | $576 | $603 | $606 |
| Liabilities | – | – | – | – |
| Payables | $6 | $7 | $4 | $4 |
| Short-Term Debt | $13 | $6 | $4 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $14 | $38 | $35 | $62 |
| Other Curr. Liab. | $35 | $34 | $28 | $23 |
| Total Curr. Liab. | $68 | $86 | $71 | $93 |
| LT Debt | $75 | $78 | $13 | $14 |
| Deferred Rev, NC | $0 | $17 | $28 | $39 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $75 | $95 | $42 | $54 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $88 | $85 | $17 | $18 |
| Total Liabilities | $142 | $181 | $113 | $146 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$755 | -$531 | -$384 | -$229 |
| AOCI | -$1 | -$1 | -$5 | -$1 |
| Other Equity | $1,592 | $926 | $879 | $689 |
| Total Equity | $836 | $395 | $490 | $460 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $978 | $576 | $603 | $606 |
| Net Debt | -$32 | -$25 | -$51 | -$30 |